AnaptysBio stock price target raised to $37 from $32 at Leerink Partners
PositiveFinancial Markets

AnaptysBio has received a boost in its stock price target, now set at $37, up from $32, according to Leerink Partners. This increase reflects growing confidence in the company's potential and could attract more investors, signaling a positive outlook for AnaptysBio's future performance in the market.
— Curated by the World Pulse Now AI Editorial System